DBV Technologies | DBVT - Trade Creditors

Stock Price
23.37
Daily Change
0.87 3.87%
Monthly
37.55%
Yearly
410.26%
Q1 Forecast
21.05

DBV Technologies reported $39.82M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Amarin USD 36.71M 8M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
DBV Technologies USD 39.82M 972K Sep/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Incyte USD 171.92M 1.24B Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Neurocrine Biosciences USD 119.9M 15.3M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
United Therapeutics USD 468M 36M Sep/2025